✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹2,705 Cr.
P/E
21.47
About
Morepen Laboratories is engaged in the manufacturing and sale of APis/ Bulk Drugs, Home Diagnostics, Formulations and OTC products. The plant at Masulkhana is for manufacture of Loratadine, an anti-al… Read more
Morepen Laboratories is engaged in the manufacturing and sale of APis/ Bulk Drugs, Home Diagno… Read more
Low
42
52W Range
High
101
  • Morepen Laboratories
  • Solara Active Pharma
  • Aarti Drugs
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

11 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
0 %
(as of Jul 22)
Anti - Diabetes - Market Share
0.07 %
(as of Jul 22)
Anti-Infectives - Market Share
1.58 %
(as of May 19)
Blood Related - Market Share
0 %
(as of Jul 22)
Cardiovascular - Market Share
0.04 %
(as of Nov 21)
Dermatology - Market Share
0.05 %
(as of Jul 22)
Gastro-Intestinal - Market Share
Revenue mix

Product Wise Break-Up

Product Wise Break-Up - Home Diagnostics / Health

Product Wise Break-Up - Active Pharmaceutical Ingredients (API) & Intermediates

Product Wise Break-Up - Finished Formulations

Location Wise Break-Up

Therapeutic Area Break-Up - Active Pharmaceutical Ingredients (API) & Intermediates

Operational Metrics

    Select a Metric
    • Global DMFs filed (.)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Brands
    Burnol
    Customers
    • Novartis India Ltd.
    FAQs on Morepen Laboratories Ltd. Business

    Morepen Laboratories is a pharmaceutical company manufacturing APis, Home Diagnostics, and OTC products. They specialize in anti-allergy drug Loratadine and are prominent in Blood Glucose Monitors and Blood Pressure Monitors domestically.

    Morepen Laboratories major competitors are Solara Active Pharma, Aarti Drugs, Bajaj Healthcare, SMS Pharmaceuticals, IOL Chem & Pharma, Themis Medicare, Hester Biosciences.
    Market Cap of Morepen Laboratories is ₹2,622 Crs.
    While the median market cap of its peers are ₹1,886 Crs.

    Morepen Laboratories seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing
    Discussions & Analysis
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material